advertisement

---

Hunter R 25

Showing records 1 to 25 | Display all abstracts from Hunter R

80617 Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial
Gazzard G
Lancet 2019; 393: 1505-1516

---

81394 Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT
Gazzard G; Konstantakopoulou E
Health Technol Assess 2019; 23: 1-102

---

80617 Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial
Konstantakopoulou E
Lancet 2019; 393: 1505-1516

---

81394 Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT
Garway-Heath D
Health Technol Assess 2019; 23: 1-102

---

80617 Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial
Garway-Heath D
Lancet 2019; 393: 1505-1516

---

81394 Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT
Garg A
Health Technol Assess 2019; 23: 1-102

---

80617 Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial
Garg A
Lancet 2019; 393: 1505-1516

---

81394 Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT
Vickerstaff V
Health Technol Assess 2019; 23: 1-102

---

80617 Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial
Vickerstaff V
Lancet 2019; 393: 1505-1516

---

81394 Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT
Hunter R
Health Technol Assess 2019; 23: 1-102

---

80617 Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial
Hunter R
Lancet 2019; 393: 1505-1516

---

81394 Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT
Ambler G
Health Technol Assess 2019; 23: 1-102

---

80617 Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial
Ambler G
Lancet 2019; 393: 1505-1516

---

81394 Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT
Bunce C
Health Technol Assess 2019; 23: 1-102

---

80617 Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial
Bunce C
Lancet 2019; 393: 1505-1516

---

81394 Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT
Wormald R
Health Technol Assess 2019; 23: 1-102

---

80617 Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial
Wormald R; Nathwani N
Lancet 2019; 393: 1505-1516

---

81394 Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT
Nathwani N
Health Technol Assess 2019; 23: 1-102

---

80617 Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial
Barton K
Lancet 2019; 393: 1505-1516

---

81394 Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT
Barton K; Rubin G
Health Technol Assess 2019; 23: 1-102

---

80617 Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial
Rubin G
Lancet 2019; 393: 1505-1516

---

81394 Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT
Morris S
Health Technol Assess 2019; 23: 1-102

---

80617 Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial
Buszewicz M
Lancet 2019; 393: 1505-1516

---

81394 Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT
Buszewicz M
Health Technol Assess 2019; 23: 1-102

---

80617 Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial

Lancet 2019; 393: 1505-1516

---